Deregulation Will Keep U.S. Biotech Out of China

It is only through competition with China in the biotech market that Washington will ensure advanced capabilities are not so readily handed over to Chinese biotech firms (and, therefore, the Chinese military). In this way we may slow China’s development into a biotechnology superpower and give ourselves the time we need to better compete with China in this vital area.

Chinese Biotech Threatens America

“Bio-hacking, gene-doping, and genetic manipulation are not only the next frontiers for bettering human life. They are, more troublingly, the battlefields of the future. The West is unprepared. What’s worse is that many Western firms are helping to empower America’s enemies in China.”

Outlook: Trump’s North Korea Options Are Bad–But Choose He Must!

“The president’s options on North Korea are bad. However, the president must make a choice. This is the sad world we currently live in today. It’s a simple lose-lose calculation: do we lose little by dictating the course of conflict with preemptive strikes before North Korea gets fully functional ICBMs, or do we lose big by suffering a mass casualty attack and, potentially, being forced out of the Asia-Pacific entirely?”